image
Real Estate - REIT - Industrial - NASDAQ - US
$ 43.53
-0.48 %
$ 9.95 B
Market Cap
-16.12
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jul, 7, 2025.

The intrinsic value of one LINE stock under the worst case scenario is HIDDEN Compared to the current market price of 43.5 USD, Lineage, Inc. is HIDDEN

This DCF valuation model was last updated on Jul, 7, 2025.

The intrinsic value of one LINE stock under the base case scenario is HIDDEN Compared to the current market price of 43.5 USD, Lineage, Inc. is HIDDEN

This DCF valuation model was last updated on Jul, 7, 2025.

The intrinsic value of one LINE stock under the best case scenario is HIDDEN Compared to the current market price of 43.5 USD, Lineage, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart LINE

image
$62.0$62.0$60.0$60.0$58.0$58.0$56.0$56.0$54.0$54.0$52.0$52.0$50.0$50.0$48.0$48.0$46.0$46.0$44.0$44.0$42.0$42.015 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '2515 Jun15 JunJul '25Jul '25
FINANCIALS
5.34 B REVENUE
-0.03%
361 M OPERATING INCOME
190.70%
-751 M NET INCOME
-680.67%
703 M OPERATING CASH FLOW
-11.58%
-919 M INVESTING CASH FLOW
13.74%
320 M FINANCING CASH FLOW
134.95%
1.29 B REVENUE
-3.51%
56 M OPERATING INCOME
-92.01%
0 NET INCOME
100.00%
139 M OPERATING CASH FLOW
-45.91%
-138 M INVESTING CASH FLOW
63.97%
21 M FINANCING CASH FLOW
119.44%
Balance Sheet Lineage, Inc.
image
Current Assets 1.28 B
Cash & Short-Term Investments 173 M
Receivables 826 M
Other Current Assets 286 M
Non-Current Assets 17.4 B
Long-Term Investments 124 M
PP&E 12.5 B
Other Non-Current Assets 4.74 B
4.43 %67.03 %25.42 %Total Assets$18.7b
Current Liabilities 1.49 B
Accounts Payable 1.22 B
Short-Term Debt 56 M
Other Current Liabilities 217 M
Non-Current Liabilities 7.47 B
Long-Term Debt 6.76 B
Other Non-Current Liabilities 714 M
13.61 %75.39 %7.96 %Total Liabilities$9.0b
EFFICIENCY
Earnings Waterfall Lineage, Inc.
image
Revenue 5.34 B
Cost Of Revenue 3.58 B
Gross Profit 1.76 B
Operating Expenses 1.4 B
Operating Income 361 M
Other Expenses 1.11 B
Net Income -751 M
6b6b5b5b4b4b3b3b2b2b1b1b00(1b)(1b)5b(4b)2b(1b)361m(1b)(751m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
33.00% GROSS MARGIN
33.00%
6.76% OPERATING MARGIN
6.76%
-12.43% NET MARGIN
-12.43%
-7.69% ROE
-7.69%
-3.56% ROA
-3.56%
1.87% ROIC
1.87%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Lineage, Inc.
image
2b2b2b2b1b1b1b1b1b1b800m800m600m600m400m400m200m200m00(200m)(200m)(400m)(400m)201420142015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -751 M
Depreciation & Amortization 876 M
Capital Expenditures -691 M
Stock-Based Compensation 215 M
Change in Working Capital -55 M
Others 422 M
Free Cash Flow 12 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Lineage, Inc.
image
Wall Street analysts predict an average 1-year price target for LINE of $81.2 , with forecasts ranging from a low of $42 to a high of $105 .
LINE Lowest Price Target Wall Street Target
42 USD -3.51%
LINE Average Price Target Wall Street Target
81.2 USD 86.61%
LINE Highest Price Target Wall Street Target
105 USD 141.21%
Price
Max Price Target
Min Price Target
Average Price Target
110110100100909080807070606050504040Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
4. DIVIDEND ANALYSIS
1.00% DIVIDEND YIELD
0.527 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
2.00002.00001.80001.80001.60001.60001.40001.40001.20001.20001.00001.00000.80000.80000.60000.60000.40000.40000.20000.20000.00000.00000.52750.52750.380.52751.960.002024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
6. Ownership
Insider Ownership Lineage, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
1.7 M USD 3
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Equity REITs: Takeaways From REITWeek 2025 REITs are positioned for accelerating earnings growth in 2026-2027, with management teams expressing increased optimism despite ongoing macro uncertainties. Key investment themes include AI-driven data centers, senior housing benefiting from demographic trends, and residential REITs capitalizing on the housing shortage. REITs offer resilient cash flows, potential dividend growth, and superior capital access, making them attractive relative to other asset classes in the current environment. seekingalpha.com - 2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lineage, Inc.- LINE NEW YORK , July 2, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Lineage, Inc. ("Lineage" or the "Company") (NASDAQ: LINE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. prnewswire.com - 2 weeks ago
Lineage to Report Second-Quarter 2025 Financial Results on August 6, 2025 NOVI, Mich.--(BUSINESS WIRE)--Lineage, Inc. (NASDAQ: LINE), announced that it will report its financial results for the second quarter of 2025 on Wednesday, August 6, 2025, before market open. A conference call to discuss these results has been scheduled for 8:00 a.m. Eastern Time on Wednesday, August 6, 2025. A live webcast of the call will be available on the Lineage Investor Relations website at ir.onelineage.com. An audio replay of the conference call will be available for one week followin. businesswire.com - 2 weeks ago
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR BEMARITUZUMAB IN FIBROBLAST GROWTH FACTOR RECEPTOR 2b (FGFR2b) POSITIVE FIRST-LINE GASTRIC CANCER At an Interim Analysis, Bemarituzumab Plus Chemotherapy Significantly Improved Overall Survival in People With FGFR2b Overexpression Compared to Chemotherapy Alone THOUSAND OAKS, Calif. , June 30, 2025 /PRNewswire/ -- Amgen ( NASDAQ:AMGN ) today announced the Phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy (mFOLFOX6) met its primary endpoint of overall survival (OS) at a pre-specified interim analysis. prnewswire.com - 2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lineage, Inc.- LINE NEW YORK , June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Lineage, Inc. ("Lineage" or the "Company") (NASDAQ: LINE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. prnewswire.com - 3 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lineage, Inc.- LINE NEW YORK , June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Lineage, Inc. ("Lineage" or the "Company") (NASDAQ: LINE).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. prnewswire.com - 3 weeks ago
Lineage, Inc. (LINE) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN LINEAGE, INC. (LINE), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at how. businesswire.com - 3 weeks ago
Securities Fraud Investigation Into Lineage, Inc. (LINE) Continues – Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON LINEAGE, INC. (LINE), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On April 30, 2025, Lineage reported first quar. businesswire.com - 3 weeks ago
Lineage, Inc. Declares Dividend for Second Quarter 2025 NOVI, Mich.--(BUSINESS WIRE)--Lineage, Inc. (NASDAQ: LINE) (the "Company"), the world's largest global temperature-controlled warehouse REIT, today announced that its Board of Directors has declared a cash dividend of $0.5275 per share for the second quarter of 2025. The dividend will be paid on July 21, 2025, to shareholders of record of the Company's common stock as of the close of business on June 30, 2025. About Lineage Lineage, Inc. (NASDAQ: LINE) is the world's largest global temperature-. businesswire.com - 4 weeks ago
Securities Fraud Investigation Into Lineage, Inc. (LINE) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON LINEAGE, INC. (LINE), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On April 30, 2025, Lineage reported first quarter 2025 financial results, in. businesswire.com - 4 weeks ago
Lineage Streamlines Import Process with Newly Certified Customs Bonded Warehouse Space in Seattle NOVI, Mich.--(BUSINESS WIRE)--Lineage's Seattle – Garfield facility becomes the company's first certified customs bonded cold storage warehouse in the state of Washington. businesswire.com - 1 month ago
PREFORMED LINE PRODUCTS ANNOUNCES QUARTERLY DIVIDEND CLEVELAND , June 18, 2025 /PRNewswire/ -- The Board of Directors of Preformed Line Products (Nasdaq: PLPC) on June 18, 2025, declared a regular quarterly dividend in the amount of $.20 per share on the Company's common shares, payable July 20, 2025, to shareholders of record at the close of business on July 1, 2025. ABOUT PLP PLP protects the world's most critical connections by creating stronger and more reliable networks. prnewswire.com - 1 month ago
8. Profile Summary

Lineage, Inc. LINE

image
COUNTRY US
INDUSTRY REIT - Industrial
MARKET CAP $ 9.95 B
Dividend Yield 1.00%
Description Lineage, Inc. engages in the provision of temperature-controlled warehouse real estate investment trust (REIT). It operates through the Global Warehousing and Global Integrated Solutions segments. The Global Warehousing segment composes of industrial real estate properties to provide temperature-controlled warehousing services to its customers. The Global Integrated Solutions segment consists of specialized cold-chain services. The company was founded in 2008 and is headquartered in Novi, MI.
Contact 46500 Humboldt Drive, Novi, MI, 48377 https://www.onelineage.com
IPO Date July 25, 2024
Employees 26000
Officers Ms. Abigail S. Fleming Senior Vice President & Chief Accounting Officer Mr. Timothy Smith Chief Commercial Officer Mr. Kevin Patrick Marchetti Co-Founder & Co-Executive Chairman Mr. Jeffrey Rivera Global Chief Operations Officer Mr. Sudarsan Thattai Chief Information Officer & Chief Transformation Officer Mr. R. Evan Barbosa Vice President of Investor Relations Mr. W. Gregory Lehmkuhl Chief Executive Officer, President & Director Ms. Natalie Matsler Chief Legal Officer & Corporate Secretary Mr. Adam Forste Co-Founder & Co-Executive Chairman Mr. Robert C. Crisci Chief Financial Officer